LORI ISLE: Open Payments
NPI 1568929172 · INDEPENDENCE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$559 in 41 payments from 7 companies in 2025. Trend: 2023 $119 · 2024 $433 · 2025 $559
Food & beverage: $559
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $203 |
| ABBVIE INC. | 19 | $197 |
| Novo Nordisk Inc | 4 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Lilly USA, LLC | 1 | $14 |
Products named: AIRSUPRA, VRAYLAR, BREZTRI, QULIPTA, CAPLYTA, UBRELVY, Wegovy, FARXIGA.
Industry payments across KS — which companies pay providers there.
